openPR Logo
Press release

Biosimulation Market Size & Share By Top Leading Companies and Manufacturers "Accelrys inc., Schrodinger, ACD/Labs, LeadScope, Certara, Rhenovia, Archimedes, Genedata and Insilico BioTechnology"

01-15-2019 08:37 PM CET | Health & Medicine

Press release from: Allied Market Research

Biosimulation Market

Biosimulation Market

Biosimulation refers to simulation of biological processes by means of computer program. Biosimulation technology has wide application in drug discovery and development. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials. The report provides in-depth analysis of the different segments for global biosimulation market and comprehensively determines the market drivers, major constraints and potential opportunities. Pin-point analysis of leading company profiles and their strategies would be helpful to professionals to gain the competitive intelligence. Complete assessment of past and current market trends would be helpful for future projections.

Download Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/381

Drug discovery process involves huge investment and failure of drug molecule in the late phase, results in wastage of efforts and money. Hence, there is necessity to develop a tool that will outlay the future drug molecule during discovery phase. This is the prime reason that drives the growth of global biosimulation market. Further, the growth is supported by high healthcare expenditure, advanced software programs and improved simulation technology. Limited knowledge of biological processes, lack of standard methods for biosimulation and high risk of failure of drugs in biosimulation are the major restrains for global biosimulation market. However, increasing accuracy of the technique and integration with other methods for better predictions would be helpful to minimize these restrains.

Global Biosimulation Market by Application

The global biosimulation market has two broad application categories, namely drug discovery and drug development. Applications in drug discovery includes Lead identification, Lead optimization, Target identification, Target validation; whereas, applications in drug development include, Preclinical testing and clinical trials and Patient validation. Application of pharmacokinetic/pharmacodynamic model (PKPD) in pre-clinical testing would be the most opportunistic area for the growth of drug discovery and drug development process.

Global Biosimulation Market by Geography

Geographically, global biosimulation market is segmented into North America, Europe, Asia and LAMEA. North America commands the global biosimulation market and holds more than half of the share value as compared to total global sale. This growth in North America is significantly driven by off patenting of many drugs and search for new drug moiety. Europe stands next to North America for global biosimulation market where growth is majorly driven by government initiatives. Asia-pacific is emerging market where the growth is driven by increase in number of CRO’s.

Get Detail Information @ https://www.alliedmarketresearch.com/purchase-enquiry/381

Competitive Landscape

Global biosimulation market is highly competitive, which is dominated by few big players; whereas, rest of the market is highly fragmented. The leading companies in global biosimulation market include

• Accelrys inc.,
• Schrodinger,
• ACD/Labs,
• LeadScope,
• Certara,
• Rhenovia,
• Archimedes,
• Genedata and
• Insilico BioTechnology.

Companies are focusing on the strategy of collaborations and partnerships to aid the innovation. Accelrys Inc. has signed a three-year agreement with Pfizer for the use of its modeling and simulation software by Pfizer’s researchers worldwide.

High Level Analysis

Market dynamics are focused with market drivers, challenges and opportunities, which would be helpful to understand market behavior. Competitive landscape section explicitly covers key players, collaborations, partnerships and agreements, and it would prove beneficial to understand the niche market trends. Porter’s five forces analysis have been used to determine the attractiveness of global biosimulation market. Bargaining power of supplier is high as there is less or no threat of backward integration by buyers. Biosimulation technology reduces the total cost of drug discovery and development for pharmaceutical manufacturers. Hence, there is high demand for simulation software and buyers group is less concentrated, which would be sufficient to decrease the buyers bargaining power. Biosimulation techniques need understanding of biological processes and systems, and it also requires standardization of simulation methodology. Lack of expertise in this field puts the threat from substitute and new entrants on low risk situation.

Table Of Content

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Access Full Summery @ https://www.alliedmarketresearch.com/biosimulation-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market Size & Share By Top Leading Companies and Manufacturers "Accelrys inc., Schrodinger, ACD/Labs, LeadScope, Certara, Rhenovia, Archimedes, Genedata and Insilico BioTechnology" here

News-ID: 1500763 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Biosimulation

Key Trends Influencing the Growth of the Biosimulation Market in 2025: Innovatio …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Biosimulation Market Through 2025? The size of the biosimulation market has seen a significant increase lately. This market is projected to expand from a total value of $4.47 billion in 2024 to $5.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. The historic
Global Healthcare Expenditure Boosts Biosimulation Market Growth: A Significant …
The Biosimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Biosimulation Market Size and Projected Growth Rate? The size of the biosimulation market has expanded significantly in the past few years. Starting from a valuation of $4.47 billion in 2024, it's forecasted to
Primary Catalyst Driving Biosimulation Market Evolution in 2025: Global Healthca …
What market dynamics are playing a key role in accelerating the growth of the biosimulation market? The anticipated rise in global healthcare expenditure is predicted to bolster the biosimulation market throughout the forecast period. The uptick in healthcare expenses is expected to increase spending on drug development, consequently fueling revenue from biosimulation solutions. Currently, biosimulation software is utilized in drug development to imitate diseases. This software enables the conduct of virtual
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032. Biosimulation, which involves the use of
Global Biosimulation Market Research Report 2023-2029
Biosimulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimulation market is projected to reach US$ 3686.5 million in 2029, increasing from US$ 1580.2 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2029. Demand from Hospital and Scientific Research Institutions are the major drivers for the industry. Global Biosimulation Market: Driven factors and Restrictions factors The research
Biosimulation Technology Market - Precision Modeling, Transformative Insights: B …
Newark, New Castle, USA: The "Biosimulation Technology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biosimulation Technology Market: https://www.growthplusreports.com/report/biosimulation-technology-market/7766 This latest report researches the industry structure, sales, revenue,